Pharmaceutical UK-based Acacia Pharma says that positive results from a Phase III study of Baremsis (amisulpride injection) as a treatment for established post-operative nausea and vomiting (PONV) have been published in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists (ASA) (Kranke et al.). Positive headline results were first announced by the Company in January 2016. 15 March 2018